From the CEO
Welcome to the inaugural issue of The Teal Journal: The Ovarian Cancer National Alliance Periodical of Progress. For the past fourteen years, OCNA has been at the forefront of advocating for women diagnosed with ovarian cancer. As the national voice on Capitol Hill, we have played a significant role in raising the level of funding allocated for research into ovarian cancer. We walk the halls of Congress, share our stories with the medical community and are a force for change among... Read More
OCNA Interviews Dr. Kohn in a No Holds Barred Interview
In a rare and candid interview, Dr. Elise Kohn talks with the Ovarian Cancer National Alliance about finding a cure, CA-125 and clinical trials at NCI. Read More Read More
Ask the Expert
Dr. Karlan answers your questions about ovarian cancer prevention, surgery and treatment. 1. Is surgery necessary for every patient suspected of having ovarian cancer? What about second or third surgeries? Traditionally, the best way to make a definitive diagnosis of ovarian cancer is by surgery, since the surgical procedure serves as both a diagnostic and an important therapeutic intervention. Debulking surgery (the removal of all visible ovarian cancer) is a cornerstone of... Read More
Laboratory Developed Tests: What Goes Wrong?
Ovarian cancer early detection tests fall under a complicated regulatory scheme In this issue of The Teal Journal: The Ovarian Cancer National Alliance Periodical of Progress, each one of the articles touches on the question that is, for the ovarian cancer community, the elephant in the room. Why, after all the millions of dollars that are spent on research, has it been impossible to develop a screening test for ovarian cancer? Since neither the CA-125 nor the transvaginal sonogram... Read More
What is Your Personal Risk of Being Diagnosed with Ovarian Cancer?
Fewer than half of women know their actual risk of developing ovarian cancer. The implication for clinicians is that while efforts to raise awareness about ovarian cancer have been successful, the next educational frontier needs to focus on how to help women understand the role their genetic profile has as a predictor of cancer. “Almost all women hover somewhere between a 1% and 5% lifetime risk of ovarian cancer…but by far the most important risk factors…are mediated by... Read More
